JA - Standards Development for Regenerative Medicine Therapies
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- FDA-JA-1224405
- Agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- GS10F-176AA-75F40120F80487 Federal contract award
- Awardee
- Nexight Group LLC
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- B599 Special Studies/Analysis- Other
- Place of performance
- Silver Spring MD 20993 USA
Notice details come from SAM.gov. Updated .
Notice text
JA for FDA-INT-1224405 per attachment "FDA-JA-1224405 CBER_OTAT Regenerative Medicine Therapies".
Awarded contract GS10F-176AA to unknown vendor for unknown amount on 2020-09-22.
Files
| File | Type | Posted |
|---|---|---|
| FDA-JA-1224405 CBER_OTAT Regenerative Medicine Therapies.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Limited / Sole Source Justification | |
| Notice of Intent to Sole Source - Standards Development for Regenerative Medicine Therapies | Special Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity